Table 2. Bivariate analysis of baseline characteristics and incidence of diabetes in patients with prediabetes at 3 years follow-up.
Variable | HR (95%) CI) |
---|---|
Gender | |
Men | 1.00 |
Women | 1.01 (0.73–1.41) |
Age | |
30–49 years | 1,00 |
50–64 years | 0.93 (0.58–1.47) |
65–74 years | 0.94 (0.58–1.54) |
Educational level | |
Less than secondary | 1.00 |
Secondary or higher | 0.88 (0.62–1.25) |
Family history of diabetes | |
No | 1.00 |
Yes | 1.58 (1.13–2.21) |
Tobacco consumption | |
Smoker | 1.00 |
Ex-smoker | 1.49 (0.89–2.48) |
Never smoker | 1.16 (0.69–1.95) |
Alcohol consumption | |
None | 1.00 |
Low risk | 0.74 (0.52–1.07) |
High risk or harmful | 0.85 (0.51–1.43) |
Daily consumption of fruits | |
No | 1.00 |
Yes | 0.57 (0.40–0.81) |
Daily consumption of vegetables | |
No | 1.00 |
Yes | 1.04 (0.75–1.46) |
Complete breakfast | |
No | 1.00 |
Yes | 0.71 (0.46–1.09) |
Regular physical activity | |
No | 1.00 |
Yes | 0.74 (0.53–1.03) |
BMI (kg/m2) | |
<30 | 1.00 |
≥30 | 1.80 (1.29–2.51) |
Abdominal circumference (cm) | |
<88 cm (women)/ <102 cm (men) | 1.00 |
≥88 cm (women)/ ≥102 cm (men) | 2.21 (1.44–3.38) |
Blood pressure (mmHg) | |
<140/90 | 1.00 |
≥140/90 | 1.58 (1.13–2.20) |
Liver enzymes (U/L) | |
AST ≤35 | 1.00 |
AST >35 | 2.18 (1.39–3.41) |
ALT ≤35 | 1.00 |
ALT >35 | 1.93 (1.34–2.76) |
GGT ≤40 | 1.00 |
GGT >40 | 1.66 (1.18–2.35) |
Lipid profile (mg/dL) | |
Total cholesterol <250 | 1.00 |
Total cholesterol ≥250 | 0.85 (0.51–1.42) |
HDL cholesterol <40 (men)/ <50 (women) | 1.00 |
HDL cholesterol ≥40 (men)/ ≥50 (women) | 0.58 (0.41–0.82) |
LDL cholesterol <100 | 1.00 |
LDL cholesterol ≥100 | 0.87 (0.58–1.30) |
Triglycerides <150 | 1.00 |
Triglycerides ≥150 | 1.63 (1.16–2.30) |
Metabolic syndrome | |
No | 1.00 |
Yes | 3.02 (2.14–4.26) |
Fatty liver index | |
<30 | 1.00 |
30–60 | 2.22 (0.97–5.11) |
≥60 | 4.52 (2.10–9.72) |
ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; FPG, fasting plasma glucose; GGT, gamma glutamyltranspeptidase; HDL, high density lipoprotein; HR, hazard ratio; LDL, low density lipoprotein; SBP, systolic blood pressure